Companies: 10,795·Total market cap: $144.5T
Health Catalyst, Inc.

Health Catalyst, Inc.

HCATNASDAQHealthcare● Active
$1.75
$-0.19(-9.59%)
Market Cap$128945030
P/E Ratio
52W High$4.291
52W Low$0.955
Overview

Health Catalyst, Inc. (HCAT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · HCAT · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.72hcat eps ttm · hcat earnings per shareEarnings history
PE Ratio (TTM)hcat pe ratio ttm · hcat price to earningsPE Ratio deep dive
Revenue (TTM)$302.5Mhcat revenue ttm · hcat annual revenueFull revenue history
Dividend YieldNo Dividenddoes hcat pay dividends · hcat dividend yieldDividend history
Shares Outstanding69.9Mhcat shares outstanding · hcat floatShares outstanding history
Next EarningsAug 6, 2026Est.hcat earnings date · hcat next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$311.1M▲ +1.48% YoY
202320242025
health catalyst, inc. revenue · hcat revenue 2025
FY 2025Net Income-$178.0M▼ 156.07% YoY
202320242025
health catalyst, inc. net income · hcat profit 2025
FY 2025EPS$-2.55▼ 121.74% YoY
202320242025
hcat eps · health catalyst, inc. earnings per share 2025
TTM:Revenue: $302.5MNet Income: -$265.3MEPS: $-3.72View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy22 analystsis hcat a buy · hcat analyst rating
Strong Buy
0
Buy
12
Hold
10
Sell
0
Strong Sell
0
12-Month Price Target
$1.75Low
$1.75Current
$2.25Avg Target28.94% upside
$3.00High
hcat price target · hcat 12 month forecast

Total: 22 · Buy rate: 54.5%

The HCAT analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $2.25, representing +28.94% upside from the current price of $1.75.

Stock Performance

Full History
1D-9.59%
1W+29.26%
1M+14.80%
3M-10.51%
YTD-26.99%
1Y-58.05%
5Y-97.02%

About Health Catalyst, Inc.

CEOBenjamin Albert
IPO DateJul 25, 2019
Employees1,500
CountryUS

Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data a…

what is health catalyst, inc. · hcat stock overview · health catalyst, inc. company profile · who is health catalyst, inc. ceo · hcat NASDAQ · health catalyst, inc. headquarters · health catalyst, inc. business segments

About Stock Overview & Key Data

Health Catalyst, Inc. (HCAT) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Jul 25, 2019. As of the latest trading session, HCAT stock price is $1.75, with a market capitalization of $128.9M. The stock has returned -58.05% over the past 12 months and -26.99% year-to-date.

According to 22 Wall Street analysts, the consensus rating for Health Catalyst, Inc. stock is Buy, with an average 12-month price target of $2.25. In fiscal year 2025, Health Catalyst, Inc. reported revenue of $311.1M and net income of -$178.0M. For detailed data — including Health Catalyst, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Health Catalyst, Inc. (HCAT) stock price is $1.75. The stock is traded on NASDAQ under the ticker symbol HCAT. The 52-week range is $0.95 – $4.29.

HCAT stock priceHCAT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice